Rare diseases
Investigational molecules
Locations
Back to Greece1 004 clinical trials in Piraeus, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
GreeceStudy Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
GreeceStudy on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa
GreeceStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy
GreeceStudy of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer
GreeceStudy on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis
GreeceStudy Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency
GreeceStudy of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer
GreeceStudy on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus
GreeceStudy on Carfilzomib and Ibrutinib for Patients with Waldenström’s Macroglobulinemia
GreeceStudy of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments
GreeceStudy on Iberdomide for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem Cell Transplantation
GreeceThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, particularly in non-small cell lung cancer and novel therapeutic combinations. Studies include investigations of targeted therapies and immunotherapy approaches.
Innovative research combining standard treatments with new therapeutic agents to improve patient outcomes.
Research initiatives targeting heart failure prevention and stroke prevention in patients with atrial fibrillation. Studies evaluate new therapeutic approaches for managing cardiovascular risks.
Trials focusing on both preventive measures and treatment of established cardiovascular conditions.
Clinical investigations in multiple myeloma and related blood disorders, exploring combination therapies and novel treatment approaches for patients with various blood-related conditions.
Studies examining innovative therapeutic combinations for improved patient outcomes.
Research focusing on treating Crohn's Disease and other inflammatory conditions, evaluating new therapeutic options and combination treatments for better disease management.
Studies aimed at improving treatment outcomes in chronic inflammatory diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
